PUBLISHER: 360iResearch | PRODUCT CODE: 1590819
PUBLISHER: 360iResearch | PRODUCT CODE: 1590819
Genome Engineering Market by Technology, Application, End-User - Global Forecast 2025-2030
The Genome Engineering Market was valued at USD 6.33 billion in 2023, expected to reach USD 7.32 billion in 2024, and is projected to grow at a CAGR of 15.68%, to USD 17.57 billion by 2030.
Genome engineering, a transformative area within biotechnology, encompasses techniques and technologies developed to manipulate an organism's genetic material. Its scope includes methods such as CRISPR-Cas9, TALENs, and ZFNs, which have broadened possibilities in areas like gene therapy, agriculture, and synthetic biology. The necessity of genome engineering lies in its potential to address pervasive challenges such as genetic disorders, crop resilience, and the development of biofuels. Its applications are diverse, covering therapeutic uses like eradicating genetic diseases, enhancing agricultural productivity through genetically modified crops, and advancing personalized medicine by customizing treatments based on genomic data.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2023] | USD 6.33 billion |
| Estimated Year [2024] | USD 7.32 billion |
| Forecast Year [2030] | USD 17.57 billion |
| CAGR (%) | 15.68% |
The end-use scope spans healthcare, agriculture, pharmaceuticals, and industrial biotechnology. Key growth influencers in this market include advancements in genome editing technologies, increasing funding from government bodies and private institutions, and rising demand for biotechnological innovations to improve health outcomes and food security. Emerging opportunities are particularly visible in gene therapy and precision medicine, with markets poised to benefit significantly from breakthroughs that allow for precise genetic modifications. Companies are advised to invest in R&D, focusing on the development of improved, efficient, and cost-effective genome editing tools while keeping abreast of regulatory frameworks and ethical considerations.
However, the market faces limitations and challenges, including ethical concerns around genetic manipulation and stringent regulatory requirements that can hinder rapid commercialization. High costs associated with genome editing procedures and limited technical expertise in some regions also pose significant hurdles. Innovation and research should target overcoming these difficulties, with promising areas including advancements in delivery mechanisms to improve efficiency and reduce costs, exploring novel applications in microbiome engineering, and developing eco-friendly gene drives for pest control.
Overall, the genome engineering market, characterized by rapid growth and technological advancements, presents significant opportunities but requires strategic navigation of ethical and regulatory landscapes to realize its full potential.
Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genome Engineering Market
The Genome Engineering Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.
- Market Drivers
- Growing demand for synthetic gene in biotechnology sector
- Rising implementation of CRISPR genome editing technology
- Increasing adoption in diagnostics sector worldwide
- Market Restraints
- High equipment/systems costs in genome engineering
- Market Opportunities
- Constant technological developments in gene-editing tools
- Emerging application in personalized medicine
- Market Challenges
- Issues associaetd with genetic engineering
Porter's Five Forces: A Strategic Tool for Navigating the Genome Engineering Market
Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genome Engineering Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.
PESTLE Analysis: Navigating External Influences in the Genome Engineering Market
External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genome Engineering Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.
Market Share Analysis: Understanding the Competitive Landscape in the Genome Engineering Market
A detailed market share analysis in the Genome Engineering Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.
FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genome Engineering Market
The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genome Engineering Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.
Strategy Analysis & Recommendation: Charting a Path to Success in the Genome Engineering Market
A strategic analysis of the Genome Engineering Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.
Key Company Profiles
The report delves into recent significant developments in the Genome Engineering Market, highlighting leading vendors and their innovative profiles. These include Bluebird Bio, Inc., CRISPR Therapeutics AG, Danaher Corporation, Editas Medicine, Inc., GenScript Biotech Corporation, Horizon Discovery Group PLC, Intellia Therapeutics, Inc., Lonza Group AG, Merck & Co., Inc., New England Biolabs, Origene Technologies, Precision BioSciences, Inc., Sangamo Therapeutics, Inc., Thermo Fisher Scientific Inc., and Transposagen Biopharmaceuticals, Inc..
Market Segmentation & Coverage
This research report categorizes the Genome Engineering Market to forecast the revenues and analyze trends in each of the following sub-markets:
- Based on Technology, market is studied across Clustered Regularly Interspaced Short Palindromic Repeats, Transcription Activator-like Effector Nuclease, and Zinc Finger Nuclease.
- Based on Application, market is studied across Animal Genetic Engineering, Cell Line Engineering, and Plant Genome Engineering.
- Based on End-User, market is studied across Academic & Government Research Institutes, Biotechnology & Pharmaceutical Companies, and Contract Research Organizations.
- Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.
The report offers a comprehensive analysis of the market, covering key focus areas:
1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.
2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.
3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.
4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.
5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.
The report also answers critical questions to aid stakeholders in making informed decisions:
1. What is the current market size, and what is the forecasted growth?
2. Which products, segments, and regions offer the best investment opportunities?
3. What are the key technology trends and regulatory influences shaping the market?
4. How do leading vendors rank in terms of market share and competitive positioning?
5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?
Table of Contents
1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Stakeholders
2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Growing demand for synthetic gene in biotechnology sector
- 5.1.1.2. Rising implementation of CRISPR genome editing technology
- 5.1.1.3. Increasing adoption in diagnostics sector worldwide
- 5.1.2. Restraints
- 5.1.2.1. High equipment/systems costs in genome engineering
- 5.1.3. Opportunities
- 5.1.3.1. Constant technological developments in gene-editing tools
- 5.1.3.2. Emerging application in personalized medicine
- 5.1.4. Challenges
- 5.1.4.1. Issues associaetd with genetic engineering
- 5.1.1. Drivers
- 5.2. Market Segmentation Analysis
- 5.3. Porter's Five Forces Analysis
- 5.3.1. Threat of New Entrants
- 5.3.2. Threat of Substitutes
- 5.3.3. Bargaining Power of Customers
- 5.3.4. Bargaining Power of Suppliers
- 5.3.5. Industry Rivalry
- 5.4. PESTLE Analysis
- 5.4.1. Political
- 5.4.2. Economic
- 5.4.3. Social
- 5.4.4. Technological
- 5.4.5. Legal
- 5.4.6. Environmental
6. Genome Engineering Market, by Technology
- 6.1. Introduction
- 6.2. Clustered Regularly Interspaced Short Palindromic Repeats
- 6.3. Transcription Activator-like Effector Nuclease
- 6.4. Zinc Finger Nuclease
7. Genome Engineering Market, by Application
- 7.1. Introduction
- 7.2. Animal Genetic Engineering
- 7.3. Cell Line Engineering
- 7.4. Plant Genome Engineering
8. Genome Engineering Market, by End-User
- 8.1. Introduction
- 8.2. Academic & Government Research Institutes
- 8.3. Biotechnology & Pharmaceutical Companies
- 8.4. Contract Research Organizations
9. Americas Genome Engineering Market
- 9.1. Introduction
- 9.2. Argentina
- 9.3. Brazil
- 9.4. Canada
- 9.5. Mexico
- 9.6. United States
10. Asia-Pacific Genome Engineering Market
- 10.1. Introduction
- 10.2. Australia
- 10.3. China
- 10.4. India
- 10.5. Indonesia
- 10.6. Japan
- 10.7. Malaysia
- 10.8. Philippines
- 10.9. Singapore
- 10.10. South Korea
- 10.11. Taiwan
- 10.12. Thailand
- 10.13. Vietnam
11. Europe, Middle East & Africa Genome Engineering Market
- 11.1. Introduction
- 11.2. Denmark
- 11.3. Egypt
- 11.4. Finland
- 11.5. France
- 11.6. Germany
- 11.7. Israel
- 11.8. Italy
- 11.9. Netherlands
- 11.10. Nigeria
- 11.11. Norway
- 11.12. Poland
- 11.13. Qatar
- 11.14. Russia
- 11.15. Saudi Arabia
- 11.16. South Africa
- 11.17. Spain
- 11.18. Sweden
- 11.19. Switzerland
- 11.20. Turkey
- 11.21. United Arab Emirates
- 11.22. United Kingdom
12. Competitive Landscape
- 12.1. Market Share Analysis, 2023
- 12.2. FPNV Positioning Matrix, 2023
- 12.3. Competitive Scenario Analysis
- 12.4. Strategy Analysis & Recommendation
Companies Mentioned
- 1. Bluebird Bio, Inc.
- 2. CRISPR Therapeutics AG
- 3. Danaher Corporation
- 4. Editas Medicine, Inc.
- 5. GenScript Biotech Corporation
- 6. Horizon Discovery Group PLC
- 7. Intellia Therapeutics, Inc.
- 8. Lonza Group AG
- 9. Merck & Co., Inc.
- 10. New England Biolabs
- 11. Origene Technologies
- 12. Precision BioSciences, Inc.
- 13. Sangamo Therapeutics, Inc.
- 14. Thermo Fisher Scientific Inc.
- 15. Transposagen Biopharmaceuticals, Inc.
LIST OF FIGURES
- FIGURE 1. GENOME ENGINEERING MARKET RESEARCH PROCESS
- FIGURE 2. GENOME ENGINEERING MARKET SIZE, 2023 VS 2030
- FIGURE 3. GLOBAL GENOME ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. GLOBAL GENOME ENGINEERING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 5. GLOBAL GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. GLOBAL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
- FIGURE 7. GLOBAL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 8. GLOBAL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 9. GLOBAL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 10. GLOBAL GENOME ENGINEERING MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 11. GLOBAL GENOME ENGINEERING MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 12. AMERICAS GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 13. AMERICAS GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 14. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 15. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 16. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 17. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 18. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 19. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 20. GENOME ENGINEERING MARKET SHARE, BY KEY PLAYER, 2023
- FIGURE 21. GENOME ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2023
LIST OF TABLES
- TABLE 1. GENOME ENGINEERING MARKET SEGMENTATION & COVERAGE
- TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
- TABLE 3. GLOBAL GENOME ENGINEERING MARKET SIZE, 2018-2030 (USD MILLION)
- TABLE 4. GLOBAL GENOME ENGINEERING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 5. GLOBAL GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 6. GENOME ENGINEERING MARKET DYNAMICS
- TABLE 7. GLOBAL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 8. GLOBAL GENOME ENGINEERING MARKET SIZE, BY CLUSTERED REGULARLY INTERSPACED SHORT PALINDROMIC REPEATS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 9. GLOBAL GENOME ENGINEERING MARKET SIZE, BY TRANSCRIPTION ACTIVATOR-LIKE EFFECTOR NUCLEASE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 10. GLOBAL GENOME ENGINEERING MARKET SIZE, BY ZINC FINGER NUCLEASE, BY REGION, 2018-2030 (USD MILLION)
- TABLE 11. GLOBAL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 12. GLOBAL GENOME ENGINEERING MARKET SIZE, BY ANIMAL GENETIC ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
- TABLE 13. GLOBAL GENOME ENGINEERING MARKET SIZE, BY CELL LINE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
- TABLE 14. GLOBAL GENOME ENGINEERING MARKET SIZE, BY PLANT GENOME ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
- TABLE 15. GLOBAL GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 16. GLOBAL GENOME ENGINEERING MARKET SIZE, BY ACADEMIC & GOVERNMENT RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 17. GLOBAL GENOME ENGINEERING MARKET SIZE, BY BIOTECHNOLOGY & PHARMACEUTICAL COMPANIES, BY REGION, 2018-2030 (USD MILLION)
- TABLE 18. GLOBAL GENOME ENGINEERING MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2030 (USD MILLION)
- TABLE 19. AMERICAS GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 20. AMERICAS GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 21. AMERICAS GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 22. AMERICAS GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 23. ARGENTINA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 24. ARGENTINA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 25. ARGENTINA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 26. BRAZIL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 27. BRAZIL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 28. BRAZIL GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 29. CANADA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 30. CANADA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 31. CANADA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 32. MEXICO GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 33. MEXICO GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 34. MEXICO GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 35. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 36. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 37. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 38. UNITED STATES GENOME ENGINEERING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
- TABLE 39. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 40. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 41. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 42. ASIA-PACIFIC GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 43. AUSTRALIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 44. AUSTRALIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 45. AUSTRALIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 46. CHINA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 47. CHINA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 48. CHINA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 49. INDIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 50. INDIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 51. INDIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 52. INDONESIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 53. INDONESIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 54. INDONESIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 55. JAPAN GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 56. JAPAN GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 57. JAPAN GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 58. MALAYSIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 59. MALAYSIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 60. MALAYSIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 61. PHILIPPINES GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 62. PHILIPPINES GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 63. PHILIPPINES GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 64. SINGAPORE GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 65. SINGAPORE GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 66. SINGAPORE GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 67. SOUTH KOREA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 68. SOUTH KOREA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 69. SOUTH KOREA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 70. TAIWAN GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 71. TAIWAN GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 72. TAIWAN GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 73. THAILAND GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 74. THAILAND GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 75. THAILAND GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 76. VIETNAM GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 77. VIETNAM GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 78. VIETNAM GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 79. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 80. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 81. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 82. EUROPE, MIDDLE EAST & AFRICA GENOME ENGINEERING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
- TABLE 83. DENMARK GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 84. DENMARK GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 85. DENMARK GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 86. EGYPT GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 87. EGYPT GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 88. EGYPT GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 89. FINLAND GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 90. FINLAND GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 91. FINLAND GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 92. FRANCE GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 93. FRANCE GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 94. FRANCE GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 95. GERMANY GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 96. GERMANY GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 97. GERMANY GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 98. ISRAEL GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 99. ISRAEL GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 100. ISRAEL GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 101. ITALY GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 102. ITALY GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 103. ITALY GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 104. NETHERLANDS GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 105. NETHERLANDS GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 106. NETHERLANDS GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 107. NIGERIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 108. NIGERIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 109. NIGERIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 110. NORWAY GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 111. NORWAY GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 112. NORWAY GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 113. POLAND GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 114. POLAND GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 115. POLAND GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 116. QATAR GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 117. QATAR GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 118. QATAR GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 119. RUSSIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 120. RUSSIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 121. RUSSIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 122. SAUDI ARABIA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 123. SAUDI ARABIA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 124. SAUDI ARABIA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 125. SOUTH AFRICA GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 126. SOUTH AFRICA GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 127. SOUTH AFRICA GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 128. SPAIN GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 129. SPAIN GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 130. SPAIN GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 131. SWEDEN GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 132. SWEDEN GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 133. SWEDEN GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 134. SWITZERLAND GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 135. SWITZERLAND GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 136. SWITZERLAND GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 137. TURKEY GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 138. TURKEY GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 139. TURKEY GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 140. UNITED ARAB EMIRATES GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 141. UNITED ARAB EMIRATES GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 142. UNITED ARAB EMIRATES GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 143. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
- TABLE 144. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
- TABLE 145. UNITED KINGDOM GENOME ENGINEERING MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
- TABLE 146. GENOME ENGINEERING MARKET SHARE, BY KEY PLAYER, 2023
- TABLE 147. GENOME ENGINEERING MARKET, FPNV POSITIONING MATRIX, 2023
